GlassScriptPhysician profile
Amy L Hallow
NPI 1871260281
$4,269.64
in general payments reported to CMS, 2019-2025
17 companies · $537 in 2025
The $537 reported for 2025 was more than what 76% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $103 · 2022: $600 · 2023: $2,571 · 2024: $458 · 2025: $537.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,749 · Travel and Lodging: $718 · Education: $99.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,748.77 |
| Travel and Lodging | $717.81 |
| Education | $99.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $1,457.89 | 2023 | Watchman Access System, Watchman Flx |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $898.92 | 2022-2025 | Lifevest |
| Astrazeneca Pharmaceuticals LP | $486.08 | 2021-2024 | Farxiga, Brilinta |
| Amgen INC. | $410.06 | 2021-2025 | Repatha, Repatha |
| Boehringer Ingelheim Pharmaceuticals, INC. | $286.34 | 2022-2024 | Jardiance |
| Novartis Pharmaceuticals Corporation | $166.61 | 2021-2025 | |
| Bridgebio Pharma, INC. | $124.46 | 2025 | Attruby |
| Endologix LLC | $102.00 | 2022 | |
| E.R. Squibb & Sons, L.L.C. | $99.70 | 2023 | Camzyos |
| W. L. Gore & Associates, INC. | $76.70 | 2025 | Gore Viabahn Vbx Balloon Expandable Endo |
| Zoll Circulation INC | $38.00 | 2023 | Therox Ds2 Console, Downstream Cartridge, Catheter |
| Janssen Pharmaceuticals, INC | $36.29 | 2021-2022 | |
| Edwards Lifesciences Corporation | $25.84 | 2025 | Pascal |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $17.92 | 2021 | |
| Pfizer INC. | $16.11 | 2025 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amarin Pharma, INC. | $14.15 | 2022 | |
| Merck Sharp & Dohme LLC | $12.57 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amy Hallow listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.